American Bitcoin Conducts Reverse Stock Split To Avoid Delisting

2 hours ago 1

CryptoProwl

Fri, July 3, 2026 astatine 8:49 AM CDT 2 min read

American Bitcoin (NASDAQ: $ABTC) has conducted a arguable reverse banal divided to debar being delisted from the Nasdaq (NASDAQ: $NDAQ) speech connected which its shares trade. 

American Bitcoin is the Bitcoin (CRYPTO: $BTC) mining institution co-founded by U.S. President Donald Trump's lad Eric and majority-owned by Canada's Hut 8 (NASDAQ: $HUT).

The company's shares are presently trading astatine $0.56 U.S. per share, having fallen 91% since going nationalist past year. 

More From Cryptoprowl:

The existent stock terms puts American Bitcoin successful information of being delisted signifier the Nasdaq, which requires companies to support their stock terms supra $1 U.S.  

To hole the occupation and debar delisting, American Bitcoin executed a reverse 1-for-15 banal divided connected July 2, artificially lifting its banal terms backmost supra the Nasdaq's minimum threshold.

ABTC banal volition statesman trading connected a split-adjusted ground erstwhile U.S. markets reopen connected July 6. 

Reverse banal splits thin to beryllium frowned upon by investors who presumption them arsenic artificially boosting a stock terms without fixing the underlying problems astatine a company. 

The determination volition shrink American Bitcoin's full stock number from 1.09 cardinal to astir 73 million. The shares are expected to statesman trading connected July 6 astatine $8.40 U.S. 

American Bitcoin runs large-scale mining operations portion accumulating Bitcoin connected its equilibrium sheet.

The institution went nationalist done a peculiar intent acquisition institution (SPAC) merger past September arsenic portion of a propulsion by Hut 8 to buildout American Bitcoin's infrastructure.

However, ABTC banal has steadily declined arsenic Bitcoin's terms fell from an all-time precocious of $126,000 U.S. past October to $58,000 U.S. successful June of this year.

HUT banal has risen 344% successful the past 12 months to commercialized astatine $97.14 U.S. per share. 

Read Entire Article